Product image of Magaldrato Doc (Magaldrate) supplied by GNH India

Magaldrato Doc

Active Ingredient:
Magaldrate
Origin:
EU

Magaldrato Doc (Magaldrate)

Magaldrate, the active ingredient in Magaldrato Doc, is an antacid presented as an oral tablet for oral use. It neutralizes excess stomach acid and is used to relieve symptoms such as heartburn, dyspepsia and acid indigestion in adults and children, and is available over the counter in many EU countries.

GNH India supplies Magaldrato Doc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance across European and global markets.

Manufacturer / TM Owner

Doc Generici S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Magaldrate acts on gastric acidity and is indicated for several common gastrointestinal conditions.

  • Heartburn: provides rapid relief of burning sensation by raising gastric pH.
  • Dyspepsia: eases upper abdominal discomfort and fullness after meals.
  • Acid indigestion: reduces the sour taste and discomfort caused by excess acid.
  • Gastric hyperacidity: helps maintain a balanced gastric environment in chronic acid over‑production.

How It Works

  • Magaldrate neutralizes gastric hydrochloric acid through a chemical reaction that forms magnesium and aluminum salts together with water. This reaction raises the pH of stomach contents, decreasing acidity and providing symptomatic relief of acid‑related gastrointestinal discomfort.

Side Effects

Magaldrate is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Constipation: mild to moderate difficulty in bowel movements.
  • Diarrhoea: loose stools, often transient.
  • Nausea: feeling of unease or upset stomach.
  • Flatulence: increased intestinal gas.
  • Metallic taste: temporary alteration in taste perception.
  • Abdominal discomfort: mild cramping or pain.

Serious or Rare Side Effects

  • Electrolyte imbalance: especially in patients with renal impairment.
  • Severe constipation or intestinal blockage.
  • Allergic reactions: rash, itching, swelling, or anaphylaxis.
  • Metabolic alkalosis: rare over‑correction of acidity.
  • Hypermagnesemia: elevated magnesium levels in susceptible individuals.
  • Renal function deterioration: in patients with pre‑existing kidney disease.

Precautions & Warnings

Before using Magaldrato Doc, consider the following safety measures.

  • Pregnancy: safety not established; use only if potential benefit outweighs risk.
  • Breastfeeding: unknown safety profile; exercise caution.
  • Renal impairment: monitor magnesium load and adjust use accordingly.
  • Drug interactions: antacids may affect absorption of other oral medications; separate dosing times.
  • Pediatric use: administer only under medical supervision and appropriate dosing.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Avoid Interactions

Magaldrate can affect the absorption and efficacy of several medicines.

Major Interactions (Avoid)

  • Tetracycline antibiotics: reduced absorption leading to therapeutic failure.
  • Fluoroquinolone antibiotics: decreased bioavailability.
  • Iron supplements: diminished iron uptake.
  • Digoxin: possible increase in serum concentration.

Moderate Interactions (Monitor Closely)

  • Warfarin: potential alteration of INR values.
  • Lithium: risk of increased lithium levels.
  • Beta‑blockers: may reduce absorption and efficacy.

Frequently Asked Questions

Magaldrato Doc contains magaldrate, an antacid that is used to relieve symptoms of heartburn, dyspepsia, acid indigestion and other conditions caused by excess gastric acid. It works by neutralising stomach acidity, providing rapid symptomatic relief.

Magaldrate reacts chemically with hydrochloric acid in the stomach, forming magnesium and aluminium salts together with water. This neutralisation raises the gastric pH, reducing acidity and alleviating discomfort associated with acid‑related gastrointestinal disorders.

The dosage of Magaldrato Doc is determined by the prescribing healthcare professional based on the individual’s condition, age, and response to therapy. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for magaldrate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and under the guidance of a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Magaldrate combines magnesium and aluminium compounds, offering a balanced neutralising effect with a lower risk of severe constipation compared with aluminium‑only antacids and less diarrhoea than magnesium‑only products. Unlike H2‑blockers or proton‑pump inhibitors, it works by direct chemical neutralisation rather than altering acid production.

Store Magaldrato Doc at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture, heat and direct sunlight to maintain stability and potency.

Magaldrato Doc is taken orally, usually with a glass of water. It can be taken with or without food, but if other oral medications are prescribed, they should be spaced at least two hours apart to avoid absorption interference.

Serious risks include electrolyte disturbances such as hypermagnesemia, severe constipation leading to intestinal blockage, allergic reactions that may progress to anaphylaxis, and rare cases of metabolic alkalosis. Patients with renal impairment should be monitored closely.

Magaldrato Doc should be avoided in individuals with known hypersensitivity to magaldrate or its components, in patients with severe renal failure unless medically supervised, and in those who require strict control of magnesium intake. Consultation with a healthcare professional is essential before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Magaldrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT